ArticleNucleic acids research2026
Photocaged FLP recombinase for precise spatio-temporal control of gene expression.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The ability to precisely control gene expression is fundamental to studying biological processes. Using site-specific recombinases such as FLP, gene expression can be controlled, albeit with limited spatio-temporal precision. We develop a photocaged FLP recombinase, which can be precisely controlled using light, and we demonstrate its efficacy in Caenorhabditis elegans. We use genetic code expansion to incorporate photocaged amino acids into FLP, replacing critical residues in the active site with their photocaged counterparts. Photocaged FLP displays no detectable background activity, and brief illumination can be used to activate FLP with near 100% efficiency. We show that photocaged FLP can be activated by light between 365 and 435 nm, and that it is not activated by light above 450 nm, making it fully compatible with wavelengths commonly used for imaging and optogenetics. Furthermore, we demonstrate that photocaged FLP can be used to switch on expression of target genes in individual cells within the animal using a standard 405 nm microscope-mounted laser to deliver the activating light. Activation by laser requires illumination times of <10 ms per cell. Thus, we have developed a straightforward and efficient tool to precisely control gene expression in the multicellular organism C. elegans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.